2025’s Biggest Takeaways for Medical Device Manufacturers

As 2025 comes to a close, the medical device manufacturing industry continues to advance rapidly. Evolving clinical needs, new technologies, and increasing global demand for high-performance components are reshaping how devices are designed and produced. 

This year has highlighted three major areas of growth that are influencing development priorities across the industry: the continued rise of minimally invasive procedures driving smaller and more advanced devices, the ongoing focus on supply chain stability, and the accelerating adoption of Pulsed Field Ablation (PFA) catheter technologies. 

1. The Growth of Minimally Invasive Procedures Is Driving Smaller, More Advanced Devices

The global shift toward minimally invasive procedures shows no sign of slowing down. Physicians are increasingly demanding devices that can reach deeper, navigate more complex anatomies, and perform with precision, all while being smaller, stronger, and more flexible. 

At Confluent, our Polymer Tubing and Catheter Components are engineered to meet these exacting standards. From ultra-thin wall tubing to complex multi-layer constructions, our polymer capabilities enable miniaturization without compromising strength or kink resistance. 

Confluent’s new Ultra Polyimide offers nearly double the strength of traditional polyimide while maintaining valuable inner lumen space. This allows for greater support in delivery device technology designed for tighter anatomies. 

Meanwhile, our Nitinol capabilities bring superelastic and shape-memory performance to devices used in neurovascular, electrophysiology, and structural heart procedures. As demand grows for Nitinol’s unique properties, performance, and reliability become even more critical. Confluent’s high-purity ELI material delivers exceptional strength and fatigue resistance, supporting continued device miniaturization without sacrificing durability or functionality. 

2. Supply Chain Stability Remains a Critical Industry Priority

In the post-pandemic era, supply chain resilience has become more than a buzzword—it’s a business imperative and a key competitive advantage. Device manufacturers are seeking partners who can provide consistent quality, scalability, and risk mitigation across global operations. 

Confluent’s vertically integrated manufacturing and in-house expertise across both Nitinol and Polymer Tubing technologies mean our customers benefit from a single, trusted partner for multiple critical components. 

In early 2024, Confluent announced a strategic partnership with industry leader ATI, creating a fully integrated Nitinol supply chain. This partnership enhances industry-wide stability for this critical alloy while providing customers with the highest-quality material and industry-leading lead times. 

The benefits of vertical integration are also clear in our Balloon Catheter manufacturing. With in-house extrusion capabilities, our experts maintain full control over balloon design and quality—enabling rapid design iteration, tighter quality control, and faster lead times for complex components. 

From balloons, catheters, Nitinol, textiles, and polymer tubing, Confluent offers end-to-end control over materials, design, and production to ensure stability and precision at every step. 

3. The Rise of PFA Catheters Is Accelerating Innovation

The global Pulsed Field Ablation (PFA) device market has experienced rapid growth throughout 2025, with forecasts showing a steep upward trajectory as more providers adopt the technology. 

PFA is transforming cardiac electrophysiology, introducing a new energy modality that demands catheters with precision energy delivery, complex tip integration, and exceptional material performance—a challenge Confluent is uniquely equipped to meet. 

Our deep expertise in Complex Catheter design and manufacturing allows us to support PFA catheter development from early prototyping through full-scale production. By leveraging our Nitinol Component capabilities for electrode design and our Polymer Tubing expertise for complex shaft assemblies, Confluent provides the integrated engineering necessary to bring next-generation PFA devices to life. 

As the field of PFA continues to expand, our partners trust Confluent to accelerate innovation—without ever compromising on quality or performance. 

Looking Ahead: Partnering for What’s Next 

2025 reaffirmed a simple truth: success in the medical device industry depends on quality, reliability, and partnership. 

As devices become smaller, smarter, and more complex, Confluent Medical Technologies remains the trusted partner for companies seeking innovation without compromise. 

Ready to bring your next breakthrough to life? 
Let’s build the future of medical device technology—together. 

Email sales@confluentmedical.com to start your next project.